Peter J. Rix
Launchpad Central (United States)(US)Cardiff Metropolitan University(GB)
Publications by Year
Research Areas
Estrogen and related hormone effects, Prostate Cancer Treatment and Research, Advanced Breast Cancer Therapies, Computational Drug Discovery Methods, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment(2012)654 cited
- → Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer(2013)262 cited
- → Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts(2015)245 cited
- → The Pharmacology of Bimatoprost (Lumigan™)(2001)213 cited
- → Metal enrichment in bauxites by deposition of chemically mature aeolian dust(1988)210 cited
- → The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer(2016)117 cited